Neoadjuvant Treatment in Resectable Pancreatic Cancer. Is It Time for Pushing on It?

Overview of attention for article published in Frontiers in oncology, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 12 X posts from 11 X users, with an upper bound of 35,426 followers.

📣Mini Review: Neoadjuvant Treatment in Resectable #PancreaticCancer. Is It Time for Pushing on It? 👨‍⚕️👩‍⚕️ Vivarelli M et al Read here 👉 https://t.co/kxd1QFJuc9 #CAncerTreatment #Oncology

RT @DottAndri: Neoadjuvant Treatment in Resectable Pancreatic Cancer. Is It Time for Pushing on it or going on with upfront surgery? We bel…

RT @DottAndri: Neoadjuvant Treatment in Resectable Pancreatic Cancer. Is It Time for Pushing on it or going on with upfront surgery? We bel…

RT @DottAndri: Neoadjuvant Treatment in Resectable Pancreatic Cancer. Is It Time for Pushing on it or going on with upfront surgery? We bel…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.